(Q39874794)
Statements
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent (English)
Anthony J Mutsaers
Giulio Francia
Shan Man
Christina R Lee
Yan Wu
Larry Witte
Scott Berry
Malcolm Moore
Robert S Kerbel